New Strong Sell Stocks for September 16th

AGCO, BSX and BBWI have been added to the Zacks Rank #5 (Strong Sell) List on September 16th, 2026.

Zacks Investment Research • 2 hours ago

Boston Scientific: A Great Company At A Deeply Discounted Price (Rating Upgrade)

Boston Scientific is upgraded to 'Strong Buy' as market overreaction creates an attractive entry point for long-term investors. BSX trades at a forward P/E of 13.1, well below its historical average, despite robust profitability and solid Q2 2026 results. Growth headwinds from WATCHMAN and electrophysiology are offset by strong Interventional Cardiology and Vascular Therapies momentum.

Seeking Alpha • a day ago

Boston Scientific Leans on Acquisitions to Drive Long-Term Growth

BSX's deal-making push expands its reach into high-growth markets, with Penumbra adding a major thrombectomy opportunity.

Zacks Investment Research • Sep 14, 2026

Is Boston Scientific (BSX) a Buy as Wall Street Analysts Look Optimistic?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Zacks Investment Research • Sep 11, 2026

Boston Scientific: $43 Finally Prices In A Bad 2026

Boston Scientific's cyberattack will hurt third-quarter results, but manufacturing and shipping recovered quickly enough that much of the missing revenue should be delayed rather than lost. I am more concerned about WATCHMAN and U.S. electrophysiology, which had already slowed before the attack, and the additional debt coming with Penumbra. BSX shares now trade near 13 times the company's withdrawn earnings forecast. I estimate fair value at $55, leaving enough room for a Buy without assuming that growth immediately returns.

Seeking Alpha • Sep 11, 2026

Boston Scientific Restores Key Operations After Cyberattack

The company said products are moving through its distribution network at or above normal levels as the Marlborough, Mass., company works to fulfill customer orders, reduce backlogs and accelerate the delivery of products.

WSJ • Sep 10, 2026

Boston Scientific Corporation (BSX) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

Boston Scientific Corporation (BSX) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

Seeking Alpha • Sep 10, 2026

Why Boston Scientific (BSX) Dipped More Than Broader Market Today

Boston Scientific (BSX) reached $43.1 at the closing of the latest trading day, reflecting a -4.14% change compared to its last close.

Zacks Investment Research • Sep 10, 2026

Boston Scientific says cyberattack likely to hurt 2026 sales, profit

Boston Scientific ‌said on Tuesday a cybersecurity incident ​that disrupted ​manufacturing and order shipments ⁠globally is likely ​to have a ​material impact on its third-quarter and full-year ​2026 results.

Reuters • Sep 8, 2026

Boston Scientific Slammed After Cyberattack Hamstrings Sales, Profit

Boston Scientific said Tuesday a cybersecurity incident is likely to have a material impact on its third-quarter and full-year results.

Investors Business Daily • Sep 8, 2026